MedPath

Validation of the Diagnostic Performance of the Sleep Apnea Syndrome by the Withings HWA09 Device

Conditions
Sleep Apnea
Interventions
Diagnostic Test: HWA09 Measurement
Registration Number
NCT04496843
Lead Sponsor
Withings
Brief Summary

Sleep Apnea Syndrome (SAS) is a common pathology affecting between 4 and 8% of the general population. It aggravates morbidity and cardio-metabolic mortality and is responsible for accidents related to vigilance disorders. It is estimated that 80%% of SAS cases are not diagnosed and therefore not treated. It is however impracticable to propose a diagnostic test of polygraphy (PG) or polysomnography (PSG) to every patient because of the cost and insufficient availability of these exams. It would therefore be useful to carry out a screening test before directing the patient to a complete test.

Several simplified polygraph systems with 2 or 3 channels have been proposed (nasal cannula, oximetry, heart rate) but they generally record only one night and remain intrusive enough to perturb the sleep.

The Withings HWA09 is a wrist-worn watch, which allows screening of SAS from four signals: movement, heart rate, breathing rate and blood oxygen saturation (SpO2). The objective of the present study is to validate the diagnostic performance of the Withings HWA09 for the detection of SAS compared to PSG.

Detailed Description

Subjects are patients having a prescription for a one-night polysomnographic consultation in order to diagnose potential sleep disorders. The investigator will collect the consent before including any patient in this study. The study last one night per patient, during which saturation signal recordings and the sleep apnea detection will be made by the HWA09 watch, in comparison to the polysomnography.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
220
Inclusion Criteria
  • Adults, men and women, between 18 and 70 y/o
  • Patient addressed for a polysomnography because of a suspicion of sleep respiratory disorders
  • Subject having expressed his/her consent to take part in the study
Exclusion Criteria
  • Recording under continuous positive pressure
  • Subject having refuse to give his/her consent
  • Vulnerable subjects according to regulation in force :
  • Pregnant, parturient or breastfeeding women
  • Subjects having a known allergy to one of the components of the sensor (silicon, stainless steel, sapphire glass)
  • Subjects deprived of liberty by a court, medical or administrative order
  • Subjects legally protected or unable to express their non-opposition to take part in the study
  • Subjects unable to express their consent due to linguistic or mental incapacities

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients referred for an overnight in-lab PSGHWA09 MeasurementSimultaneous assessment of SAS with Withings HWA09 Device and overnight PSG
Primary Outcome Measures
NameTimeMethod
Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 5/h in PSG1 year

Sensitivity and specificity for SAS detection by Withings HWA09 compared to PSG at apnea-hypopnea index (AHI) threshold value of 5/h in PSG.

Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 15/h in PSG1 year

Sensitivity and specificity for SAS detection by Withings HWA09 compared to PSG at AHI threshold value of 15/h in PSG.

Sensitivity and Specificity of Withings HWA09 at AHI threshold value of 30/h in PSG1 year

Sensitivity and specificity for SAS detection by Withings HWA09 compared to PSG at AHI threshold value of 30/h in PSG.

Secondary Outcome Measures
NameTimeMethod
Sensitivity and Specificity of the desaturation detected by Withings HWA091 year

Sensitivity and specificity of the desaturation detection by Withings HWA09 compared to an oximeter with the Oxygen Desaturation Index (ODI)

Accuracy of Withings HWA09 to estimate total sleep time (TST) given by PSG1 year

Bias and mean absolute error (MAE)

Impact of the proportion of apnea events on the performance of Withings HWA091 year

Bias and MAE for apnea index (AI) estimated by Withings HWA09 compared to PSG results

Impact of the proportion of hypopnea events on the performance of Withings HWA091 year

Bias and MAE for hypopnea index (HI) estimated by Withings HWA09 compared to PSG results

Influence of the position of the sleeper (supine vs prone/lateral decubitus position) on the error of the AHI predicted by Withings HWA09 compared with PSG1 year

Average difference of AHI between Withings HWA09 and the PSG in each position

Reliability of Withings HWA091 year

Rate of unusable of lost nights

Trial Locations

Locations (2)

Antoine Béclère Hospital

🇫🇷

Clamart, Ile-de-France, France

St Pierre Hospital

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath